GGrantIndex
Sort

53,477 grants matching addiction

Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use

$1,028,026
Thomas Kerr · University Of British Columbia · U01 · FY2017 · DA

THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS

$1,027,800
Pamela Ann Madden · Washington University · R01 · FY2008 · DA

Cherokee Nation Prevention Trial: Interactive Effects of Environment & SBIRT

$1,027,637
Kelli Ann Komro · University Of Florida · R01 · FY2014 · AA

CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE

$1,027,634
Temple University · P30 · FY2000 · DA

Endocannabinoid Active Sites as Therapeutic Targets

$1,027,528
Alexandros Makriyannis · Northeastern University · P01 · FY2007 · DA

Digital Markers in Relapse and Recovery

$1,027,277
Brenda Curtis · National Institute On Drug Abuse · ZIA · FY2022 · DA

Structure and Function of Neurotransmitter Transporters

$1,026,736
Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · DA

ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION

$1,026,410
Rockefeller University · R01 · FY2000 · DA

Administrative Core

$1,025,848
Suchitra Krishnan-Sarin · Yale University · U54 · FY2020 · DA

"Differential Effects of Methamphetamine and Cocaine"

$1,025,411
James W Gibb · University Of Utah · P01 · FY2009 · DA

IGF::OT::IGF Medication Discovery Using Rat Models of Relapse; POP 8/29/2014-7/9/2019; FY16 N01DA-14-8917

$1,024,658
Patrick Beardsley · Virginia Commonwealth University · N01 · FY2018 · DA

Preclinical development of a TriCoil-based nicotine vaccine

$1,024,634
Christopher H Clegg · Tria Bioscience Corporation · UH2 · FY2016 · DA

Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder

$1,024,387
Keith Gregory Heinzerling · University Of California Los Angeles · R01 · FY2016 · DA

HD2A RASC-Research and Evaluation Core

$1,024,035
C. Hendricks Brown · Stanford University · U2C · FY2025 · DA

HD2A RASC-Research and Evaluation Core

$1,024,035
C. Hendricks Brown · Stanford University · U2C · FY2023 · DA

HD2A RASC-Research and Evaluation Core

$1,024,035
C. Hendricks Brown · Stanford University · U2C · FY2024 · DA

The UIUC Neuroproteomics Center on Cell-Cell Signaling

$1,023,849
University Of Illinois Urbana-Champaign · P30 · FY2005 · DA

Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing

$1,023,668
Kuan Wang · National Institute Of Mental Health · ZIA · FY2009 · MH

10/24 Healthy Brain and Child Development National Consortium

$1,023,610
Julie May Croff · Osu Center For Health Sciences · U01 · FY2021 · DA

Vaping Cessation among youth: Evaluating the feasibility and efficacy of a virtual in-person CBT and an app-based CBT4CBT

$1,023,504
Suchitra Krishnan-Sarin · Yale University · R01 · FY2025 · CA

Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation

$1,023,443
Mary A Carskadon · Emma Pendleton Bradley Hospital · R01 · FY2025 · DA

Countering Young Adult Tobacco Marketing in Bars

$1,023,400
Pamela May Ling · University Of California, San Francisco · U01 · FY2011 · CA

Development of cutting-edge optical imaging systems for in vivo imaging in live animals

$1,023,033
Da-Ting Lin · National Institute On Drug Abuse · ZIC · FY2015 · DA

Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing

$1,022,875
Kuan Wang · National Institute Of Mental Health · ZIA · FY2013 · MH

Prevention of Relapse in Addiction

$1,022,767
Kenzie Preston · National Institute On Drug Abuse · Z01 · FY2008 · DA